BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 16356810)

  • 1. Potential vascular benefits of statins.
    Kinlay S
    Am J Med; 2005 Dec; 118 Suppl 12A():62-7. PubMed ID: 16356810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and endothelial dysfunction.
    Larose E; Ganz P
    Semin Vasc Med; 2004 Nov; 4(4):333-46. PubMed ID: 15861315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
    Robinson JG
    Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-lipid-related effects of statins.
    Bellosta S; Ferri N; Bernini F; Paoletti R; Corsini A
    Ann Med; 2000 Apr; 32(3):164-76. PubMed ID: 10821323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nonlipid effects of statins on endothelial function.
    Beckman JA; Creager MA
    Trends Cardiovasc Med; 2006 Jul; 16(5):156-62. PubMed ID: 16781949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
    Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleiotropic effects of HMG-CoA reductase inhibitors.
    Bocan TM
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidative effects of statins.
    Adam O; Laufs U
    Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins and their role in vascular protection.
    Mason JC
    Clin Sci (Lond); 2003 Sep; 105(3):251-66. PubMed ID: 12793855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
    Marzilli M
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
    März W; Köenig W
    J Cardiovasc Risk; 2003 Jun; 10(3):169-79. PubMed ID: 12775949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Statins: possibly more than just lowering of the lipid level].
    Visseren FL; Lansberg PJ; Erkelens DW; Kastelein JJ
    Ned Tijdschr Geneeskd; 2000 Feb; 144(7):316-21. PubMed ID: 10707742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of statins on endothelium, inflammation and cardioprotection.
    Elrod JW; Lefer DJ
    Drug News Perspect; 2005 May; 18(4):229-36. PubMed ID: 16034478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microcirculation as a target for the anti-inflammatory properties of statins.
    Scalia R; Stalker TJ
    Microcirculation; 2002 Dec; 9(6):431-42. PubMed ID: 12483541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the laboratory: clinical implications for statin pleiotropy.
    Halcox JP; Deanfield JE
    Circulation; 2004 Jun; 109(21 Suppl 1):II42-8. PubMed ID: 15173062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?
    Schönbeck U; Libby P
    Circulation; 2004 Jun; 109(21 Suppl 1):II18-26. PubMed ID: 15173059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes].
    Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B
    Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins and the endothelium.
    Ii M; Losordo DW
    Vascul Pharmacol; 2007 Jan; 46(1):1-9. PubMed ID: 16920035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.